Osimertinib AZD9291 is a chemical compound that has gained significant attention in the pharmaceutical industry due to its critical role as an intermediate in the production of targeted cancer therapies. This article explores the key properties and applications of this important pharmaceutical intermediate, emphasizing the value it brings to drug synthesis and development.

As a white crystalline powder, Osimertinib AZD9291 is precisely manufactured to meet high standards of purity, typically exceeding 99%. This stringent quality control is essential for its use in synthesizing Active Pharmaceutical Ingredients (APIs), particularly for potent anticancer drugs. The chemical formula C28H33N7O2 and molecular weight of 499.61 are key identifiers, alongside its CAS number 1369773-39-6. These specifications are vital for researchers and manufacturers to ensure compatibility and efficacy in their synthesis processes.

The primary application of AZD9291 lies in its function as a pharmaceutical intermediate for drugs like Osimertinib, which is a TKI (Tyrosine Kinase Inhibitor) used in the treatment of specific types of lung cancer. The meticulous synthesis of such drugs relies heavily on the quality of the starting materials. Therefore, the availability of high-purity Osimertinib pharmaceutical intermediate powder from reliable suppliers is a cornerstone of modern pharmaceutical production.

Beyond its direct role in API production, AZD9291 is also valuable in pharmaceutical research and development. Its consistent properties make it an ideal compound for exploring new synthetic pathways and developing novel drug delivery systems. As the pharmaceutical industry continues to advance, the demand for high-quality, well-characterized intermediates like Osimertinib AZD9291 remains a constant, driving innovation and supporting the development of next-generation therapeutics.